Skip to main content
logo
Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0090
+0.0010 (12.50%)
Mar 25, 2026, 9:30 AM EST

Evofem Biosciences Revenue

In the year 2025, Evofem Biosciences had annual revenue of $20.18M with 4.23% growth. Evofem Biosciences had revenue of $9.56M in the quarter ending December 31, 2025, with 34.59% growth.

Revenue
20.18M
Revenue Growth
+4.23%
P/S Ratio
0.06
Revenue / Employee
695.97K
Employees
29
Market Cap
1.13M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202520.18M820.00K4.23%
Dec 31, 202419.36M1.15M6.28%
Dec 31, 202318.22M1.38M8.20%
Dec 31, 202216.84M8.59M104.23%
Dec 31, 20218.24M7.80M1,748.43%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Carisma Therapeutics52.63M
Emmaus Life Sciences11.89M
International Stem Cell9.39M
Lyra Therapeutics600.00K
Eastgate Biotech137.64K
Enzolytics46.59K
Halberd6.94K
Revenue Rankings

Evofem Biosciences News

More News